Direct reprogramming of stem cell properties in colon cancer cells by CD44 - Wikidata - wikimedia - TriplyDB

Direct reprogramming of stem cell properties in colon cancer cells by CD44

Direct reprogramming of stem cell properties in colon cancer cells by CD44

http://www.wikidata.org/entity/Q35176968

about

Pancreatic cancer stem cell markers and exosomes - the incentive push Cancer stem cells (CSCs), cervical CSCs and targeted therapies The role of CD44 in epithelial-mesenchymal transition and cancer development Racial disparity in colorectal cancer: Gut microbiome and cancer stem cells Concise Review: Emerging Role of CD44 in Cancer Stem Cells: A Promising Biomarker and Therapeutic Target Critical role for lysyl oxidase in mesenchymal stem cell-driven breast cancer malignancy Lysosomal degradation of CD44 mediates ceramide nanoliposome-induced anoikis and diminished extravasation in metastatic carcinoma cells.Serglycin in human cancers Enrichment and characterization of cancer stem‑like cells from a cervical cancer cell line.Prognostic value of CD44 expression in non-small cell lung cancer: a systematic review Prognostic role of CD44 expression in osteosarcoma: evidence from six studies.CD44 expression in intestinal epithelium and colorectal cancer is independent of p53 status Aberrantly expressed Fra-1 by IL-6/STAT3 transactivation promotes colorectal cancer aggressiveness through epithelial-mesenchymal transition.CD44 is a direct target of miR-199a-3p and contributes to aggressive progression in osteosarcoma Knockdown of CD44 inhibits the invasion and metastasis of hepatocellular carcinoma both in vitro and in vivo by reversing epithelial-mesenchymal transition.Understanding cancer stem cell heterogeneity and plasticity.An aberrant nuclear localization of E-cadherin is a potent inhibitor of Wnt/β-catenin-elicited promotion of the cancer stem cell phenotype.Regulation of stem cell plasticity: mechanisms and relevance to tissue biology and cancer.Nanog increases focal adhesion kinase (FAK) promoter activity and expression and directly binds to FAK protein to be phosphorylated.Polarized cell migration induces cancer type-specific CD133/integrin/Src/Akt/GSK3β/β-catenin signaling required for maintenance of cancer stem cell properties.Therapeutics targeting CD90-integrin-AMPK-CD133 signal axis in liver cancer.Knock out CD44 in reprogrammed liver cancer cell C3A increases CSCs stemness and promotes differentiation.Gastric stem cells and gastric cancer stem cells.Aquaporin 3 promotes the stem-like properties of gastric cancer cells via Wnt/GSK-3β/β-catenin pathway.HAb18G/CD147 promotes pSTAT3-mediated pancreatic cancer development via CD44s.G-CSF and G-CSFR are highly expressed in human gastric and colon cancers and promote carcinoma cell proliferation and migration.miR-199a-3p targets stemness-related and mitogenic signaling pathways to suppress the expansion and tumorigenic capabilities of prostate cancer stem cells.Antibody against CD44s inhibits pancreatic tumor initiation and postradiation recurrence in mice.MBD3 inhibits formation of liver cancer stem cells.Oncogenic signaling by tyrosine kinases of the SRC family in advanced colorectal cancer.Cellular reprogramming and hepatocellular carcinoma development.Helicobacter pylori infection and stem cells at the origin of gastric cancer.Cancer stem cells converted from pluripotent stem cells and the cancerous niche.Opposing effects of low versus high concentrations of water soluble vitamins/dietary ingredients Vitamin C and niacin on colon cancer stem cells (CSCs).The FOXO3/PGC-1β signaling axis is essential for cancer stem cell properties of pancreatic ductal adenocarcinoma.CD51 correlates with the TGF-beta pathway and is a functional marker for colorectal cancer stem cells.Hitting the right spot: Mechanism of action of OPB-31121, a novel and potent inhibitor of the Signal Transducer and Activator of Transcription 3 (STAT3)Osteopontin-CD44 signaling in the glioma perivascular niche enhances cancer stem cell phenotypes and promotes aggressive tumor growth.STAT3 signaling is activated preferentially in tumor-initiating cells in claudin-low models of human breast cancer.CD58, a novel surface marker, promotes self-renewal of tumor-initiating cells in colorectal cancer.

P2860

Q26741215-5CAF1A38-4361-4B6D-81B5-976EC638507D Q26747144-D22D9619-C35B-492D-9861-6C6DBC87068A Q26771509-4D04084C-C9CF-402E-97BD-1A451D7C55C2 Q28075465-6BC354FB-EF1F-4B5B-8BFC-8F03B53DB69F Q28083115-A540FF4E-8C7C-4D06-BF4D-38F8B46201C2 Q28276295-A2344DF8-098B-4829-B825-306C7B83FD73 Q30300775-2A81F642-332E-4E14-B6C1-6A902319958B Q33579353-8FC681FB-2E6C-4592-A025-09E15EDE9765 Q33747768-54715273-AB65-423A-BCA5-E737D60E1922 Q34028901-8C1F22F4-DB56-4867-86DB-382F118DDCEA Q34668490-5932FDEB-BCFA-42A8-B69B-FB9E72DA7533 Q34979644-4792D0F2-7147-4BDF-B408-F30DCAEAB80A Q35356072-1F2BD53A-386D-496F-B872-9D3B81EE6953 Q35746515-E5C5F482-C08B-44AC-8AC3-1D00072DDD5A Q35781432-E2526A12-6A5B-4813-8122-18E12C57AA4E Q35796886-3B9A5D9A-B40F-4AFA-A4AD-45245A1FA15D Q35818227-1FF3B17A-DB36-444D-AD7C-BDBC83EB9A3F Q35939439-E1F61874-65DD-4E48-92FB-8AE5D2A26E99 Q36003017-7FA583D6-9782-4589-A5FB-5B82EC361E12 Q36545955-045B70CB-CB5E-4800-A80C-02243C6941F4 Q36619069-A1E404F7-E718-436D-AA6C-3BEFF553E50F Q36689002-6B5531B4-08E7-4833-AE72-A7DFC7E36E87 Q36737793-87DD963E-8BDB-4D5D-A7C1-8C04BE105DFE Q37086074-E0A2EC70-74BA-4D7D-879F-F9817991D3D5 Q37416242-110408AF-B732-444E-8A95-E2DE82683849 Q37632106-1103DF84-8451-41FB-8C07-2556B6132194 Q37636676-AA090C90-DB5D-4656-8458-0F6AFA7FF5B3 Q37695430-6E276C2A-9755-4B88-A656-4277D7C84A04 Q37701541-7001B6E5-123D-428B-B876-B23D822D78E0 Q38031834-94E77766-FC89-4669-83E2-D564677C8851 Q38174864-FBE3A395-4154-47DB-9776-345E5D97C0A1 Q38231865-894C00EF-12A4-4DE4-BC71-A88FF55FE883 Q38235250-B720F8AC-D395-4FE2-B966-33A3BBC8E0F4 Q38649985-417D9A78-D3D5-4DAD-BDE8-183AE6CFD68C Q38703418-20DDD52F-B623-497B-B51F-6BEC2A78B03E Q38748287-B4D2F72F-434D-4E72-A368-B8C0AACFB3ED Q38898974-ABAF3EA7-238E-475C-AF42-1FE665DBC2EC Q38955683-F0AC717D-B3B9-4C2C-A865-B4F98D2A3DAF Q38988872-0867DB80-58D7-46C5-897F-8CFB3614F7AF Q39004664-DAE22150-F279-4F8F-A51E-7D6A97A6FFB9

P2860

Direct reprogramming of stem cell properties in colon cancer cells by CD44

http://www.wikidata.org/entity/Q35176968

description

2011 nî lūn-bûn

@nan

2011 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Direct reprogramming of stem cell properties in colon cancer cells by CD44

@ast

Direct reprogramming of stem cell properties in colon cancer cells by CD44

@en

type

label

Direct reprogramming of stem cell properties in colon cancer cells by CD44

@ast

Direct reprogramming of stem cell properties in colon cancer cells by CD44

@en

prefLabel

Direct reprogramming of stem cell properties in colon cancer cells by CD44

@ast

Direct reprogramming of stem cell properties in colon cancer cells by CD44

@en

P1433

Q35176968-9DE4A149-38AB-4818-B469-F784B7F140E3

P1476

Q35176968-61973245-3A4C-4026-9D54-51EEC6740676

P2093

Q35176968-226407B1-6931-4CEB-9325-7184D9F0C307

Q35176968-88A8EBDB-973E-4DB6-B256-4780B45B6308

Q35176968-B5527640-BA24-4B26-9660-2D1DEBAF9AB7

Q35176968-C3882569-2771-4AC2-9006-BD0D0597EFFC

P2860

Q35176968-03387519-F093-4487-9BC7-2A5EB3D524CD

Q35176968-03DCA27F-A798-4E4F-A3D9-AEB1AE9886E8

Q35176968-0CF59D54-A4C9-4C21-9022-20F0D325FB50

Q35176968-1A5D383D-30D0-4D28-9553-7F2D0C3CA98B

Q35176968-20E08BDA-AF94-45AA-BC43-1964A5CC88DE

Q35176968-29B4DC7F-D872-48C3-B66F-5C4268E80BBC

Q35176968-2C453E0A-160C-4049-9792-BD6846F8B5F6

Q35176968-381D2E73-EF5A-4F44-83FE-C4683A24234C

Q35176968-3A1F9774-2AEA-4EFC-B0BC-03DBF62DD5E0

Q35176968-4F01CAEF-7793-4BFD-86A1-D8F0C61708B6

P304

Q35176968-2DA90103-EC52-4690-A933-FF9A978F2567

P31

Q35176968-8D8729E8-126E-44C5-9BC0-BAEC8E60DD61

P356

Q35176968-0CB5A5A7-D089-4BE1-9894-9EC5AFF9FBD3

P407

Q35176968-ED551A3A-8988-4330-B7BB-7379450AEE21

P433

Q35176968-98730810-7FDA-4539-8DC6-096AC0DB4FF2

P478

Q35176968-215E4D20-174B-473F-B35A-C2C752707BD6

P50

Q35176968-3E1FD4F8-6879-4F48-8A07-C15B1F43C4A8

P577

Q35176968-CDB1DDE9-77E8-45A0-8A84-0F5DDEFC8F79

P5875

Q35176968-05706EBF-983B-4DB1-AFCC-8DEA89680843

P698

Q35176968-F0FF0001-BAA0-42D1-B34E-4AC604B2DD62

P932

Q35176968-C0E3ED88-DA40-4829-BEB0-70187897B01E

P356

P1433

The EMBO Journal

P1476

Direct reprogramming of stem cell properties in colon cancer cells by CD44

@en

P2093

Guan-Ying Chen

http://www.w3.org/2001/XMLSchema#string

Hsin-Mei Lai

http://www.w3.org/2001/XMLSchema#string

Jia-Lin Lee

http://www.w3.org/2001/XMLSchema#string

Ying-Jhen Su

http://www.w3.org/2001/XMLSchema#string

P2860

Induction of EMT by twist proteins as a collateral effect of tumor-promoting inactivation of premature senescence

Nuclear signalling by tumour-associated antigen EpCAM

Characterization of clonogenic multiple myeloma cells

The epithelial-mesenchymal transition generates cells with properties of stem cells

Phenotypic characterization of human colorectal cancer stem cells

Prospective identification of tumorigenic breast cancer cells

Identification and expansion of human colon-cancer-initiating cells

A human colon cancer cell capable of initiating tumour growth in immunodeficient mice

Identification of human brain tumour initiating cells

A cell initiating human acute myeloid leukaemia after transplantation into SCID mice

P304

3186-3199

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/EMBOJ.2011.211

http://www.w3.org/2001/XMLSchema#string

P407

P433

15

http://www.w3.org/2001/XMLSchema#string

P478

30

http://www.w3.org/2001/XMLSchema#string

P50

P577

2011-06-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51246315

http://www.w3.org/2001/XMLSchema#string

P698

21701559

http://www.w3.org/2001/XMLSchema#string

P932

3160185

http://www.w3.org/2001/XMLSchema#string